Vimarsana
Biggest News Aggregation in the World

Page 11 - Alkermes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alkermes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alkermes Today - Breaking & Trending Today

China Universal Asset Management Co. Ltd. Purchases 15,035 Shares of Alkermes plc (NASDAQ:ALKS) - Vimarsana News

China Universal Asset Management Co. Ltd. Purchases 15,035 Shares of Alkermes plc (NASDAQ:ALKS)

China Universal Asset Management Co. Ltd. raised its stake in shares of Alkermes plc (NASDAQ:ALKS – Free Report) by 352.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,306 shares of the company’s stock after buying an additional […]

Alkermes plc (NASDAQ:ALKS) Short Interest Up 8.1% in March - Vimarsana News

Alkermes plc (NASDAQ:ALKS) Short Interest Up 8.1% in March

Alkermes plc (NASDAQ:ALKS – Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 14,080,000 shares, an increase of 8.1% from the February 29th total of 13,020,000 shares. Based on an average trading volume of 1,840,000 shares, the […]

McGlone Suttner Wealth Management Inc. Makes New Investment in Alkermes plc (NASDAQ:ALKS) - Vimarsana News

McGlone Suttner Wealth Management Inc. Makes New Investment in Alkermes plc (NASDAQ:ALKS)

McGlone Suttner Wealth Management Inc. bought a new position in shares of Alkermes plc (NASDAQ:ALKS – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 1,073 shares of the company’s stock, valued at approximately $30,000. A number of other institutional investors also […]

Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update - Vimarsana News

Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update

Lead product candidate, nemvaleukin, is being developed to treat a wide range of solid tumors and is currently in two potentially registrational c...

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results - Vimarsana News

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Strategic shift prioritizes the development of GLP-1 implants for the treatment of obesity and chronic weight management Positive NPM-115 preclinical weight loss data comparable to semaglutide,...